Dornase alfa is the only licensed DNAse with efficacy in the treatment of CF [44] and has been demonstrated to improve lung function, reduce DNA levels, and to reduce the viscosity of airway secretions [45]. The gene discussed is DNASE1; the disease is cystic fibrosis.